[8-K] Rockwell Medical, Inc. (DE) Reports Material Event
Rockwell Medical, Inc. furnished a press release announcing its financial results for the quarter ended June 30, 2025, and attached that press release as Exhibit 99.1 to this Current Report on Form 8-K. The company explicitly states the information in Item 2.02 and Exhibit 99.1 is being furnished and therefore is not deemed "filed" for purposes of Section 18 of the Exchange Act and will not be incorporated by reference into Securities Act filings except by specific reference. Item 9.01 lists the furnished exhibits: Exhibit 99.1 (press release) and Exhibit 104 (Cover Page Interactive Data File in Inline XBRL). The report is signed on behalf of the registrant by Mark Strobeck, Chief Executive Officer.
Rockwell Medical, Inc. ha diffuso un comunicato stampa che annuncia i risultati finanziari per il trimestre chiuso il 30 giugno 2025 e ha allegato quel comunicato come Exhibit 99.1 al presente Current Report on Form 8-K. La societ脿 dichiara esplicitamente che le informazioni contenute nell'Item 2.02 e nell'Exhibit 99.1 sono state furnished e pertanto non sono considerate 'filed' ai sensi della Sezione 18 dell'Exchange Act, e non saranno incorporate per riferimento nelle comunicazioni ai sensi del Securities Act se non con riferimento specifico. L'Item 9.01 elenca gli exhibit forniti: Exhibit 99.1 (comunicato stampa) e Exhibit 104 (Cover Page Interactive Data File in Inline XBRL). Il rapporto 猫 firmato per conto del registrante da Mark Strobeck, Amministratore delegato.
Rockwell Medical, Inc. emiti贸 un comunicado de prensa que anuncia sus resultados financieros del trimestre finalizado el 30 de junio de 2025, y adjunt贸 dicho comunicado como Exhibit 99.1 a este Current Report on Form 8-K. La compa帽铆a declara expl铆citamente que la informaci贸n contenida en el Item 2.02 y en el Exhibit 99.1 ha sido furnished y, por lo tanto, no se considera 'filed' a los efectos de la Secci贸n 18 del Exchange Act, y no se incorporar谩 por referencia en las presentaciones bajo el Securities Act salvo que se haga una referencia espec铆fica. El Item 9.01 enumera los exhibits suministrados: Exhibit 99.1 (comunicado de prensa) y Exhibit 104 (Cover Page Interactive Data File en Inline XBRL). El informe est谩 firmado en nombre del registrante por Mark Strobeck, Director ejecutivo.
Rockwell Medical, Inc.電� 2025雲� 6鞗� 30鞚� 膦呺霅� 攵勱赴鞚� 鞛 瓴瓣臣毳� 氚滍憸頃橂姅 氤措弰鞛愲毳� 氚绊彫頄堨溂氅�, 頃措嫻 氤措弰鞛愲毳� 氤� Current Report on Form 8-K鞚� Exhibit 99.1搿� 觳秬頄堨姷雼堧嫟. 須岇偓電� Item 2.02 氚� Exhibit 99.1鞚� 鞝曤炒臧� furnished霅� 瓴冹澊氙�搿� Exchange Act鞚� 靹轨厴 18鞐� 霐半澕 'filed'搿� 臧勳＜霅橃 鞎婌溂氅�, 氤勲弰鞚� 韸轨爼 氇呾嫓臧� 鞐嗠姅 頃� Securities Act鞐� 霐半ジ 鞝滌稖靹滊鞐� 彀胳“搿� 韽暔霅橃 鞎婌潉 瓴冹澊霛缄碃 氇呿檿頌� 氚濏様鞀惦媹雼�. Item 9.01鞐愲姅 鞝滉车霅� 鞝勳嫓氍检澊 雮橃棿霅橃柎 鞛堨姷雼堧嫟: Exhibit 99.1(氤措弰鞛愲) 氚� Exhibit 104(Cover Page Interactive Data File in Inline XBRL). 鞚� 氤搓碃靹滊姅 霌彪鞚胳潉 雽�鞁犿晿鞐� Mark Strobeck 斓滉碃瓴届榿鞛�(Chief Executive Officer)臧� 靹滊獏頄堨姷雼堧嫟.
Rockwell Medical, Inc. a diffus茅 un communiqu茅 de presse annon莽ant ses r茅sultats financiers pour le trimestre clos le 30 juin 2025, et a joint ce communiqu茅 en tant que Exhibit 99.1 脿 ce Current Report on Form 8-K. La soci茅t茅 indique explicitement que les informations figurant 脿 l'Item 2.02 et dans l'Exhibit 99.1 sont furnished et ne sont donc pas r茅put茅es 芦 filed 禄 aux fins de la Section 18 du Exchange Act, et ne seront pas incorpor茅es par r茅f茅rence dans des documents au titre du Securities Act sauf mention expresse. L'Item 9.01 茅num猫re les exhibits fournis : Exhibit 99.1 (communiqu茅 de presse) et Exhibit 104 (Cover Page Interactive Data File in Inline XBRL). Le rapport est sign茅 au nom de l'enregistrant par Mark Strobeck, directeur g茅n茅ral.
Rockwell Medical, Inc. hat eine Pressemitteilung ver枚ffentlicht, in der die Finanzergebnisse f眉r das Quartal zum 30. Juni 2025 bekanntgegeben werden, und diese Pressemitteilung als Exhibit 99.1 diesem Current Report on Form 8-K beigef眉gt. Das Unternehmen erkl盲rt ausdr眉cklich, dass die Angaben in Item 2.02 und in Exhibit 99.1 als furnished gelten und daher nicht als 'filed' im Sinne von Abschnitt 18 des Exchange Act betrachtet werden und nicht durch Verweis in Unterlagen nach dem Securities Act einbezogen werden, es sei denn durch ausdr眉cklichen Verweis. Item 9.01 listet die bereitgestellten Exhibits auf: Exhibit 99.1 (Pressemitteilung) und Exhibit 104 (Cover Page Interactive Data File in Inline XBRL). Der Bericht ist im Namen des Registranten von Mark Strobeck, Chief Executive Officer, unterzeichnet.
- None.
- None.
Insights
TL;DR Routine Form 8-K furnished an earnings press release; the filing contains no financial figures.
This Form 8-K serves to furnish the company's quarter-end results press release rather than present financial data within the filing itself. Because the company designates the release and Item 2.02 information as "furnished," they are not asserting the heightened legal status that comes with "filed" disclosures under Section 18. For investors and analysts, the actionable content will be in the press release (Exhibit 99.1) and any Inline XBRL exhibits; the 8-K itself is procedural and therefore has a neutral immediate impact.
TL;DR This is a procedural disclosure confirming the company furnished its quarterly results and attached the associated exhibits.
The filing documents standard disclosure practice: the company furnished a press release reporting quarterly results and included the required exhibits, including an Inline XBRL cover page. The Form 8-K emphasizes that the release is "furnished" (not "filed"), which limits incorporation by reference risk. The signature by the CEO certifies the submission on behalf of the registrant. From a governance and compliance perspective, the filing appears to follow routine SEC disclosure procedures without revealing substantive new information in the 8-K text itself.
Rockwell Medical, Inc. ha diffuso un comunicato stampa che annuncia i risultati finanziari per il trimestre chiuso il 30 giugno 2025 e ha allegato quel comunicato come Exhibit 99.1 al presente Current Report on Form 8-K. La societ脿 dichiara esplicitamente che le informazioni contenute nell'Item 2.02 e nell'Exhibit 99.1 sono state furnished e pertanto non sono considerate 'filed' ai sensi della Sezione 18 dell'Exchange Act, e non saranno incorporate per riferimento nelle comunicazioni ai sensi del Securities Act se non con riferimento specifico. L'Item 9.01 elenca gli exhibit forniti: Exhibit 99.1 (comunicato stampa) e Exhibit 104 (Cover Page Interactive Data File in Inline XBRL). Il rapporto 猫 firmato per conto del registrante da Mark Strobeck, Amministratore delegato.
Rockwell Medical, Inc. emiti贸 un comunicado de prensa que anuncia sus resultados financieros del trimestre finalizado el 30 de junio de 2025, y adjunt贸 dicho comunicado como Exhibit 99.1 a este Current Report on Form 8-K. La compa帽铆a declara expl铆citamente que la informaci贸n contenida en el Item 2.02 y en el Exhibit 99.1 ha sido furnished y, por lo tanto, no se considera 'filed' a los efectos de la Secci贸n 18 del Exchange Act, y no se incorporar谩 por referencia en las presentaciones bajo el Securities Act salvo que se haga una referencia espec铆fica. El Item 9.01 enumera los exhibits suministrados: Exhibit 99.1 (comunicado de prensa) y Exhibit 104 (Cover Page Interactive Data File en Inline XBRL). El informe est谩 firmado en nombre del registrante por Mark Strobeck, Director ejecutivo.
Rockwell Medical, Inc.電� 2025雲� 6鞗� 30鞚� 膦呺霅� 攵勱赴鞚� 鞛 瓴瓣臣毳� 氚滍憸頃橂姅 氤措弰鞛愲毳� 氚绊彫頄堨溂氅�, 頃措嫻 氤措弰鞛愲毳� 氤� Current Report on Form 8-K鞚� Exhibit 99.1搿� 觳秬頄堨姷雼堧嫟. 須岇偓電� Item 2.02 氚� Exhibit 99.1鞚� 鞝曤炒臧� furnished霅� 瓴冹澊氙�搿� Exchange Act鞚� 靹轨厴 18鞐� 霐半澕 'filed'搿� 臧勳＜霅橃 鞎婌溂氅�, 氤勲弰鞚� 韸轨爼 氇呾嫓臧� 鞐嗠姅 頃� Securities Act鞐� 霐半ジ 鞝滌稖靹滊鞐� 彀胳“搿� 韽暔霅橃 鞎婌潉 瓴冹澊霛缄碃 氇呿檿頌� 氚濏様鞀惦媹雼�. Item 9.01鞐愲姅 鞝滉车霅� 鞝勳嫓氍检澊 雮橃棿霅橃柎 鞛堨姷雼堧嫟: Exhibit 99.1(氤措弰鞛愲) 氚� Exhibit 104(Cover Page Interactive Data File in Inline XBRL). 鞚� 氤搓碃靹滊姅 霌彪鞚胳潉 雽�鞁犿晿鞐� Mark Strobeck 斓滉碃瓴届榿鞛�(Chief Executive Officer)臧� 靹滊獏頄堨姷雼堧嫟.
Rockwell Medical, Inc. a diffus茅 un communiqu茅 de presse annon莽ant ses r茅sultats financiers pour le trimestre clos le 30 juin 2025, et a joint ce communiqu茅 en tant que Exhibit 99.1 脿 ce Current Report on Form 8-K. La soci茅t茅 indique explicitement que les informations figurant 脿 l'Item 2.02 et dans l'Exhibit 99.1 sont furnished et ne sont donc pas r茅put茅es 芦 filed 禄 aux fins de la Section 18 du Exchange Act, et ne seront pas incorpor茅es par r茅f茅rence dans des documents au titre du Securities Act sauf mention expresse. L'Item 9.01 茅num猫re les exhibits fournis : Exhibit 99.1 (communiqu茅 de presse) et Exhibit 104 (Cover Page Interactive Data File in Inline XBRL). Le rapport est sign茅 au nom de l'enregistrant par Mark Strobeck, directeur g茅n茅ral.
Rockwell Medical, Inc. hat eine Pressemitteilung ver枚ffentlicht, in der die Finanzergebnisse f眉r das Quartal zum 30. Juni 2025 bekanntgegeben werden, und diese Pressemitteilung als Exhibit 99.1 diesem Current Report on Form 8-K beigef眉gt. Das Unternehmen erkl盲rt ausdr眉cklich, dass die Angaben in Item 2.02 und in Exhibit 99.1 als furnished gelten und daher nicht als 'filed' im Sinne von Abschnitt 18 des Exchange Act betrachtet werden und nicht durch Verweis in Unterlagen nach dem Securities Act einbezogen werden, es sei denn durch ausdr眉cklichen Verweis. Item 9.01 listet die bereitgestellten Exhibits auf: Exhibit 99.1 (Pressemitteilung) und Exhibit 104 (Cover Page Interactive Data File in Inline XBRL). Der Bericht ist im Namen des Registranten von Mark Strobeck, Chief Executive Officer, unterzeichnet.
FAQ
What did Rockwell Medical (RMTI) disclose in this Form 8-K?
Is the press release in the 8-K considered "filed" with the SEC?
Which exhibits were included with the filing?
Who signed the Form 8-K for Rockwell Medical?
Does the 8-K itself include financial tables or results?
